| Kelly E Hlavac, PHARMD | |
|
2250 Church St, Zachary, LA 70791-2707 | |
| (225) 658-8101 | |
| Not Available |
| Full Name | Kelly E Hlavac |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2250 Church St, Zachary, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245666874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 019730 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly E Hlavac, PHARMD 2250 Church St, Zachary, LA 70791-2707 Ph: (225) 658-8101 | Kelly E Hlavac, PHARMD 2250 Church St, Zachary, LA 70791-2707 Ph: (225) 658-8101 |
News Archive
Conservation projects often attempt to enhance the water-based transport of material, energy, and organisms in natural ecosystems. River restoration, for example, commonly includes boosting maximum flow rates.
The decision by several states not to expand Medicaid health insurance for the poor may create unintended cuts for hospitals that provide uncompensated care, according to a study by John Graves, Ph.D., a Vanderbilt policy expert in the Department of Preventive Medicine.
Renishaw's novel drug delivery system, to be used in partnership with Herantis Pharma Plc's drug candidate CDNF for the treatment of Parkinson's disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union's Framework Programme for Research and Innovation.
The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.
› Verified 5 days ago
Samantha Lynn Sutton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Church St, Zachary, LA 70791 Phone: 225-658-8101 Fax: 225-658-6484 | |
Renee Michelle Vidrine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6300 Main St, Zachary, LA 70791 Phone: 225-658-4000 | |
Mr. Roy Harrison Fontenot Ii, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5061 Main St, Zachary, LA 70791 Phone: 225-654-1335 | |
Gay Koenig, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 Church St, Zachary, LA 70791 Phone: 225-654-6388 | |
John Dry, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4344 Church St, Zachary, LA 70791 Phone: 225-654-1175 Fax: 225-654-0132 | |
Mr. Joaquin Keller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5061 Main St, Zachary, LA 70791 Phone: 225-654-1335 |